Fitokimyasalların Antiviral Etkileri

AKPINAR, OZLEM; DEMİR, Tuğba

doi:10.29130/dubited.892487

Fitokimyasalların Antiviral Etkileri

Tuğba DEMİR, (Sivas Cumhuriyet Üniversitesi, Veteriner Fakültesi, Gıda Hijyeni ve Teknolojisi Bölümü, Sivas, Türkiye)

Özlem AKPINAR (Gaziosmanpaşa Üniversitesi, Mühendislik ve Doğa Bilimleri Fakültesi, Gıda Mühendisliği Bölümü, Tokat, Türkiye)

Düzce Üniversitesi Bilim ve Teknoloji Dergisi

6 2

Yıl: 2021 Cilt: 9 Sayı: 4 Sayfa Aralığı: 1519 - 1535 Metin Dili: Türkçe DOI: 10.29130/dubited.892487 İndeks Tarihi: 05-04-2022

Fitokimyasalların Antiviral Etkileri

Öz:

Bitkilerdeki aktif fitokimyasalların genetik ve fonksiyonel olarak çeşitli virüslere karşı tedavi edici uygulamalara sahip olduğu birçok çalışmayla desteklenmektedir. Bu ajanların antiviral mekanizması, serbest radikal moleküllerinin oksidatif zararlarına karşı koruma kapasiteleri, DNA'nın inhibisyonu, RNA sentezi veya viral çoğalmanın engellenmesi gibi birçok mekanizma ile açıklanabilir. Çok sayıda epidemiyolojik ve deneysel çalışma, fitokimyasalların ümit verici antiviral aktivitelere sahip olduğunu ortaya koymaktadır. Bu çalışmanın amacı bitki ekstraktlarının ve fitokimyasalların antiviral özelliklerini ve etkin antiviral uygulamalarına yönelik araştırmaları derlemektir.

Anahtar Kelime:

Antiviral Effects of Phytochemicals

Öz:

Many scientific studies support that active phytochemicals in plants have therapeutic applications genetically and functionally against various viruses. The antiviral mechanism of these agents can be explained by many mechanisms. Their capacity to protect free radical molecules against oxidative damage, DNA inhibition, inhibition of RNA synthesis and viral growth explain the antiviral mechanism of these agents. Numerous epidemiological and experimental studies have revealed that phytochemicals have promising antiviral activities. The aim of this study is to compile research on the antiviral properties of plant extracts and phytochemicals and their effective antiviral applications.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık

[1] R. Gasparini, D. Amicizia, P.L. Lai ve D. Panatto, “Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly,” Human Vaccines and Immunotherapeutics, c. 8, s. 1, ss. 21-28, 2012.
[2] L. Nováková, J. Pavlík, L. Chrenková, O. Martinec ve L. Červený, “Current antiviral drugs and their analysis in biological materials–Part II: Antivirals against hepatitis and HIV viruses,” Journal of Pharmaceutical and Biomedical Analysis, c. 147, ss. 378-399, 2018.
[3] C.C. Lai, Y. H. Liu, C.Y. Wang, Y.H. Wang, S.C. Hsueh, M.Y. Yen, W.C. Ko ve P.R. Hsueh, “Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): Facts and myths,” Journal of Microbiology, Immunology and Infection, c. 53, ss. 404-412, 2020.
[4] J. Sun, W.T. He, L. Wang, A. Lai, X. Ji, X. Zhai, G. Li, M. A. Suchard, J. Tian, J. Zhou, M. Veit ve S. Su, “COVID-19: epidemiology, evolution, and cross-disciplinary perspectives,” Trends in Molecular Medicine, c. 26, s. 5, ss. 483-495, 2020.
[5] O. Sağdıç, S. Kayacan, E. Dertli ve M. Arıcı, “Gıda güvenliği açısından COVID-19 etmeni SARS-CoV-2’nin değerlendirilmesi ve korunma yöntemleri,” Avrupa Bilim ve Teknoloji Dergisi, c. 18, ss. 927-933, 2020.
[6] A.K. Dubey, T.J. Jaisankar ve D.M. Thappa, “Clinical and morphological characteristics of herpes zoster in south India,” Indian Journal of Dermatology, c. 50 s. 4, ss. 203-213, 2005.
[7] S. Ben-Shabat, L. Yarmolinsky, D. Porat ve A. Dahan, “Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies” Drug Delivery and Translational Research, c. 10, ss. 354-367, 2019.
[8] E. De Clercq ve G. Li, “Approved antiviral drugs over the past 50 years,” Clinical Microbiology Reviews, c. 29 s. 3, ss. 695-747, 2016.
[9] J. Johari, A. Kianmehr, M.R. Mustafa, S. Abubakar ve K. Zandi, “Antiviral activity of baicalein and quercetin against the Japanese encephalitis virüs” International Journal of Molecular Sciences, c. 13, s. 12, ss. 16785-16795, 2012.
[10] A. Küçük ve Y. Yıldırım, “Antiviral İlaçlar,” Etlik Veteriner Mikrobiyoloji Dergisi, c. 30, s. 1, ss. 100-108, 2019.
[11] C.L. Lai, E. Gane, Y.F. Liaw, C.W. Hsu, S. Thongsawat, Y. Wang ve N.V. Naoumov, “Telbivudine versus lamivudine in patients with chronic hepatitis B,” New England Journal of Medicine, c. 357 s. 25, ss. 2576-2588, 2007.
[12] A. Kamali ve M. Holodniy, “Influenza treatment and prophylaxis with neuraminidase inhibitors: a review,” Infection and Drug Resistance, c. 6, ss. 187-198, 2013.
[13] A. Sancho-Ruiz, J. Sheldon ve V. Soriano, “Telbivudine: a new option fort he treatment of chronic hepatitis B,” Expert Opinion on Biological Therapy, c. 7, ss.751-761, 2007.
[14] M.M. Soltan ve A.K. Zaki, “Antiviral screening of forty-two Egyptian medicinal plants,” Journal of Ethnopharmacology, c. 126 s. 1, ss. 102-107, 2009.
[15] S. Brijesh, P. Daswani, P. Tetali, N. Antia ve T. Birdi, “Studies on the antidiarrhoeal activity of Aegle marmelos unripe fruit: Validating its traditional usage,”BMC Complementary and Alternative Medicine, c. 9, s.1, ss. 47-59, 2009.
[16] M. Gunjan, T.W. Naing, R.S. Saini, A. Ahmad, J.R. Naidu ve I. Kumar, “Marketing trends and future prospects of herbal medicine in the treatment of various disease”. World Journal of Pharmaceutical Research, c. 4, ss. 132-155, 2015.
[17] D. Biswas, S. Nandy, A. Mukherjee, D.K. Pandey ve A. Dey, “Moringa oleifera Lam. and derived phytochemicals as promising antiviral agents: A review,” South African Journal of Botany, c. 129, ss. 272-282, 2020.
[18] R. Naithani, L.C. Huma, L. E. Holland, D. Shukla, D.L. McCormick ve R.G. Mehta, “Moriarty, R.M. Antiviral activity of phytochemicals: a comprehensive review,” Mini Reviews in Medicinal Chemistry, c. 8, s. 11, ss. 1106-1133, 2008.
[19] K. Droebner, C. Ehrhardt, A. Poetter, S. Ludwig ve O. Planz, “CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice” Antiviral Research, c. 76 s. 1, ss.1-10, 2007.
[20] M.M. Alfajaro, H.J. Kim, J.G. Park, E.H. Ryu, J.Y. Kim, Y.J. Jeong ve H.J. Kwon, “Antirotaviral effects of Glycyrrhiza uralensis extract in piglets with rotavirus diarrhea,” Virology Journal, c. 9, s. 1, ss. 310-315, 2012.
[21] J.G. Choi, Y.H. Jin, H. Lee, T.W. Oh, N.H. Yim, W.K. Cho ve J.Y. Ma, “Protective effect of panax notoginseng root water extract against influenza a virus infection by enhancing antiviral interferonmediated immune responses and natural killer cell activity,” Frontiers in Immunology, c. 8, ss. 1542, 2017.
[22] G. A. Romero-Pérez, M. Egashira, Y. Harada, T. Tsuruta, Y. Oda, F. Ueda ve R. Inoue, “Orally administered Salacia reticulata extract reduces H1N1 influenza clinical symptoms in murine lung tissues putatively due to enhanced natural killer cell activity,” Frontiers in Immunology, c. 7, ss. 115-119, 2016.
[23] G. Melikian, F. Mmiro, C. Ndugwa, R. Perry ve J. B. Jackson, “Garrett, E., Semba, R.D. Relation of vitamin A and carotenoid status to growth failure and mortality among Ugandan infants with human immunodeficiency virüs,” Nutrition, c. 17 s. 7-8, ss. 567-572, 2001. 1530 [24] Z. Zakay-Rones, E. Thom, T. Wollan ve J. Wadstein, “Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections,” Journal of International Medical Research, c. 32 s. 2, ss.132-140, 2004.
[25] Z. Zakay-Rones, N. Varsano, M. Zlotnik, O. Manor, L. Regev, M. Schlesinger ve M. Mumcuoglu, “Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama,” The Journal of Alternative and Complementary Medicine, c. 1, s. 4, ss. 361-369, 1995.
[26] A.M. Morag, M. Mumcuoglu, T. Baybikov, M. Schelsinger ve Z. Zakay-Rones, “Inhibition of sensitive and acyclovir-resistant HSV-1 strains by an elderberry extract in vitro,” Z Phytother, c. 25, ss. 97-98, 1997.
[27] C. Fiore, M. Eisenhut, R. Krausse, E. Ragazzi, D. Pellati, D. Armanini ve J. Bielenberg, “Antiviral effects of Glycyrrhiza species,” Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, c. 22, s. 2, ss. 141-148, 2008.
[28] K. Rauš, S. Pleschka, P. Klein, R. Schoop ve P. Fisher, “Effect of an Echinacea-based hot drink versus oseltamivir in influenza treatment: a randomized, double-blind, double-dummy, multicenter, noninferiority clinical trial,” Current Therapeutic Research, c. 77, ss. 66-72, 2015.
[29] M.T. Moradi, M. Rafieian-Kopaei ve A. Karimi, “A review study on the effect of Iranian herbal medicines against in vitro replication of herpes simplex virüs,” Avicenna Journal of Phytomedicine, c. 6, s. 5, ss. 506-512, 2016.
[30] S.K. Lam ve T.B. Ng, “A protein with antiproliferative, antifungal and HIV-1 reverse transcriptase inhibitory activities from caper (Capparis spinosa) seeds,” Phytomedicine, c. 16, s. 5, ss. 444-450, 2009.
[31] M.J. Abad, J.A. Guerra, P. Bermejo, A. Irurzun ve L. Carrasco, “Search for antiviral activity in higher plant extracts” Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, c. 14 s. 8, ss. 604-607, 2000.
[32] L. Yarmolinsky, M. Huleihel, M. Zaccai ve S. Ben-Shabat, “Potent antiviral flavone glycosides from Ficus benjamina leaves,” Fitoterapia, c. 83 s. 2, ss. 362-367, 2012.
[33] G. Wang, H. Wang, Y. Song, C. Jia, Z. Wang ve H. Xu, “Studies on anti-HSV effect of Ficus carica leaves” Journal of Chinese Medicinal Materials, c. 27 s. 10, ss. 754-756, 2004.
[34] A. Astani, J. Reichling ve P. Schnitzler, “Melissa officinalis extract inhibits attachment of herpes simplex virus in vitro,” Chemotherapy, c. 58, s. 1, ss. 70-77, 2012.
[35] M. Parsania, M.B. Rezaee, S.H. Monavari, K. Jaimand, S.M. Mousavi-Jazayeri, M. Razazian ve M.H. Nadjarha, “Antiviral screening of four plant extracts against acyclovir resistant herpes simplex virus type-1,” Pakistan Journal of Pharmaceutical Sciences, c. 30, s. 4, ss. 1407-1411, 2017.
[36] A. Karimi, M. Rafieian-Kopaei, M.T. Moradi ve S. Alidadi, “Anti–Herpes Simplex Virus Type1 Activity and Phenolic Content of Crude Ethanol Extract and Four Corresponding Fractions of Quercus brantii L Acorn,” Journal of Evidence-Based Complementary and Alternative Medicine, c. 22, s. 3, ss. 455-461, 2017.
[37] A.M. Arabzadeh, M. Ansari-Dogaheh, F. Sharififar, M. Shakibaie ve M. Heidarbeigi, “Anti herpes simplex-1 activity of a standard extract of Zataria multiflora Boiss.,” Pakistan Journal of Biological Sciences, c. 16, s. 4, ss. 180-184, 2013.
[38] H. Nakane ve K. Ono, “Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases” Biochemistry, c. 29, s. 11, ss. 2841-2845, 1990.
[39] M. Karamese, S. Aydogdu, S. A. Karamese, U. Altoparlak ve C. Gundogdu, “Preventive effects of a major component of green tea, epigallocathechin-3-gallate, on hepatitis-B virus DNA replication” Asian Pacific Journal of Cancer Prevention, c. 16, ss. 4199-4202, 2015.
[40] J.J. Lv, S. Yu, Y.F. Wang, D. Wang, H.T. Zhu, R.R. Cheng ve Y.J. Zhang, “Anti-hepatitis B virus norbisabolane sesquiterpenoids from Phyllanthus acidus and the establishment of their absolute configurations using theoretical calculations,” The Journal of Organic Chemistry, c. 79, s. 12, ss. 5432- 5447, 2014.
[41] O. Callies, L. M. Bedoya, M. Beltrán, A. Muñoz, P. O. Calderón, A. A. Osorio ve I.L. Bazzocchi, “Isolation, structural modification, and HIV inhibition of pentacyclic lupane-type triterpenoids from Cassine xylocarpa and Maytenus cuzcoina,” Journal of Natural Products, c. 78, s. 5, ss. 1045-1055, 2015.
[42] S. Rebensburg, M. Helfer, M. Schneider, H. Koppensteiner, J. Eberle, M. Schindler ve R. BrackWerner, “Potent in vitro antiviral activity of Cistus incanus extract against HIV and Filoviruses targets viral envelope proteins,” Scientific Reports, c. 6, ss. 20394, 2016.
[43] A. Gyuris, L. Szlavik, J. Minarovits, A. Vasas, J. Molnar ve J. Hohmann, “Antiviral activities of extracts of Euphorbia hirta L. against HIV-1, HIV-2 and SIVmac251,” in Vivo, c. 23, s. 3, ss. 429-432, 2009.
[44] L. Szlávik, Á. Gyuris, J. Minárovits, P. Forgo, J. Molnár ve J. Hohmann, “Alkaloids from Leucojum vernum and antiretroviral activity of Amaryllidaceae alkaloids,” Planta Medica, c. 70, s. 9, ss. 871-873, 2004.
[45] C. Oh, J. Price, M.A. Brindley, M. P. Widrlechner, L. Qu, J.A. McCoy ve W. Maury, “Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris L.” Virology Journal, c. 8, s. 1, ss. 188-198, 2011.
[46] M.S. Farsani, M. Behbahani ve H.Z. Isfahani, “The effect of root, shoot and seed extracts of the Iranian Thymus L.(family: Lamiaceae) species on HIV-1 replication and CD4 expression” Cell Journal (Yakhteh), c. 18, s. 2, ss. 255-261, 2016.
[47] L.M. Bedoya, M.J. Abad, S. Sánchez-Palomino, J. Alcami ve P. Bermejo, “Ellagitannins from Tuberaria lignosa as entry inhibitors of HIV,” Phytomedicine, c. 17, s. 1, ss. 69-74, 2010.
[48] A.H.A. Najjari, Z. Rajabi, M.V. Marandi ve G. Dehghan, “The effect of the hexanic extracts of fig (Ficus carica) and olive (Olea europaea) fruit and nanoparticles of selenium on the immunogenicity of the inactivated avian influenza virus subtype H9N2,” In Veterinary Research Forum, c. 6, s. 3, ss. 227- 231, 2015.
[49] T. Javed, U.A. Ashfaq, S. Riaz, S. Rehman ve S. Riazuddin, “In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus” Virology Journal, c. 8 s. 1, ss. 26-32, 2011.
[50] S. Rehman, B. Ijaz, N. Fatima, S. A. Muhammad ve S. Riazuddin, “Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico study,” Biomedicine and Pharmacotherapy, c. 83, ss. 881-891, 2016.
[51] D. Angamuthu, I. Purushothaman, S. Kothandan ve R. Swaminathan, “Antiviral study on Punica granatum L., Momordica charantia L., Andrographis paniculata Nees, and Melia azedarach L., to Human Herpes Virus-3,” European Journal of Integrative Medicine, c. 28, ss. 98-108, 2019.
[52] F. Visioli, C. Galli, E. Plasmati, S. Viappiani, A. Hernandez, C. Colombo ve A. Sala, “Olive phenol hydroxytyrosol prevents passive smoking-induced oxidative stress,” Circulation, c. 102 s. 18, ss. 2169-2171, 2000.
[53] A.F. Fidan, ve Y. Dündar, “Yucca schidigera ve içerdiği saponinler ile fenolik bileşiklerinin, hipokolesterolemik ve antioksidan etkileri,” Lalahan Enstitü Dergisi, c. 47 s. 2, ss. 31-39, 2007.
[54] Y. Yuan, J.M. Tian, J. Xiao, Q. Shao ve J.M. Gao, “Bioactive metabolites isolated from Penicillium sp. YY-20, the endophytic fungus from Ginkgo biloba.” Natural Product Research, c. 28, s. 4, ss. 278-281, 2014.
[55] J. Guo, E.X. Shang, J.A. Duan, Y. Tang ve D. Qian, “Determination of ligustilide in the brains of freely moving rats using microdialysis coupled with ultra performance liquid chromatography/mass spectrometry,” Fitoterapia, c. 82, s. 3, ss. 441-445, 2011.
[56] D.D. Orhan, B. Özçelik, S. Özgen ve F. Ergun, “Antibacterial, antifungal, and antiviral activities of some flavonoids,” Microbiological Research, c. 165, s. 6, ss. 496-504, 2010.
[57] S. Park, J.I. Kim, I. Lee, S. Lee, M.W. Hwang, J.Y. Bae ve M.S. Park, “Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses,” Biochemical and Biophysical Research Communications, cc. 440, s. 1, ss. 14-19, 2013.
[58] W. Zhang, H. Qiao, Y. Lv, J. Wang, X. Chen, Y. Hou ve E. Li, “Apigenin inhibits enterovirus71 infection by disrupting viral RNA association with trans-acting factors,” PloS One, c. 9, s. 10, ss. 1-9, 2014.
[59] S. Qian, W. Fan, P. Qian, D. Zhang, Y. Wei, H. Chen ve X. Li, “Apigenin restricts FMDV infection and inhibits viral IRES driven translational activity,” Viruses, c. 7, s. 4, ss. 1613-1626, 2015.
[60] C. Shibata, M. Ohno, M. Otsuka, T. Kishikawa, K. Goto, R. Muroyama ve K. Koike, “The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels,” Virology, c. 462, ss. 42-48, 2014.
[61] A. Hakobyan, E. Arabyan, A. Avetisyan, L. Abroyan, L. Hakobyan ve H. Zakaryan, “Apigenin inhibits African swine fever virus infection in vitro,” Archives of Virology, c. 161 s. 12, ss. 3445-3453, 2016.
[62] P. Sithisarn, M. Michaelis, M. Schubert-Zsilavecz ve J. Cinatl Jr, “Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virusinfected cells,” Antiviral Research, c. 97, s. 1, ss. 41-48, 2013.
[63] W. Wu, R. Li, X. Li, J. He, S. Jiang, S. Liu ve J. Yang, “Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry,” Viruses, c. 8, s. 1, ss. 6-24, 2016.
[64] S. Ganesan, A.N. Faris, A.T. Comstock, Q. Wang, S. Nanua, M.B. Hershenson ve U.S. Sajjan, “Quercetin inhibits rhinovirus replication in vitro and in vivo” Antiviral research, c. 94, s. 3, ss. 258-271, 2012.
[65] K. Zandi, B.T. Teoh, S.S. Sam, P.F. Wong, M.R. Mustafa ve S. AbuBakar, “Antiviral activity of four types of bioflavonoid against dengue virus type-2,” Virology Journal, c. 8, s. 1, ss. 560-571, 2011.
[66] L.C. Chiang, W. Chiang, M.C. Liu ve C.C. Lin, “In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids,” Journal of Antimicrobial Chemotherapy, c. 52, s. 2, ss. 194-198, 2003.
[67] N. Neznanov, A. Kondratova, K.M. Chumakov, L. Neznanova, R. Kondratov, A.K. Banerjee ve A. V. Gudkov, “Quercetinase pirin makes poliovirus replication resistant to flavonoid quercetin,” DNA and Cell Biology, c. 27, s. 4, ss. 191-198, 2008.
[68] M. Lee, M. Son, E. Ryu, Y.S. Shin, J.G. Kim, B.W. Kang ve H. Kang, “Quercetin-induced apoptosis prevents EBV infection,” Oncotarget, c. 6, s. 14, ss. 12603- 12624, 2015.
[69] Y.L. Li, K.M. Li, M.X. Su, K.T. Leung, Y.W. Chen ve Y.W Zhang, “Studies on antiviral constituents in stems and leaves of Pithecellibium clypearia,” China Journal of Chinese Materia Medica, c. 31, s. 5, ss. 397-400, 2006.
[70] L. Bachmetov, M. Gal‐Tanamy, A. Shapira, M. Vorobeychik, T., Giterman‐Galam, P. Sathiyamoorthy ve R. Zemel, “Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity,” Journal of Viral Hepatitis, c. 19, s. 2, ss. 81-88, 2012.
[71] O. Gonzalez, V. Fontanes, S. Raychaudhuri, R. Loo, J. Loo, V. Arumugaswami ve S.W. French, “The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production,” Hepatology, c. 50, s. 6, ss. 1756-1764, 2009.
[72] B.Q. Li, T. Fu, Y. Dongyan, J.A. Mikovits, F.W. Ruscetti ve J.M. Wang, “Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry,” Biochemical and Biophysical Research Communications, c. 276, s. 2, ss. 534-538, 2000.
[73] E. Moghaddam, B.T. Teoh, S.S. Sam, R. Lani, P. Hassandarvish, Z. Chik ve K. Zandi, “Baicalin, a metabolite of baicalein with antiviral activity against dengue virüs,” Scientific Reports, c. 4, ss. 5452- 5460, 2014.
[74] H. Shi, K. Ren, B. Lv, W. Zhang, Y. Zhao, R.X. Tan ve E. Li, “Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice,” Scientific Reports, c. 6, ss. 35851-35863, 2016.
[75] Y. Jia, R. Xu, Y. Hu, T. Zhu, T. Ma, H. Wu ve L. Hu, “Anti-NDV activity of baicalin from a traditional Chinese medicine in vitro,” Journal of Veterinary Medical Science, c. 15, ss. 572-593, 2016.
[76] H. Huang, W. Zhou, H. Zhu, P. Zhou ve X. Shi, “Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs,” Toxicology and Applied Pharmacology, c. 323, ss. 36-43, 2017.
[77] D.L. Evers, C.F. Chao, X. Wang, Z. Zhang, S. M. Huong ve E.S. Huang, “Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action,” Antiviral Research, c. 68, s. 3, ss. 124-134, 2005.
[78] B.S. Konigheim, M.E. Goleniowski ve M.S. Contigiani, “Cytotoxicity and antiviral activity of a lignan extracted from Larrea divaricata,” Drug Design Reviews-Online, c. 2, s. 1, ss. 81-83, 2005.
[79] T. Demir, Ö. Akpınar, H. Kara ve H. Güngör, “Nar (Punica granatum L.) kabuğunun in vitro antidiyabetik, antienflamatuar, sitotoksik, antioksidan ve antimikrobiyal aktivitesi,” Academic Food Journal, c. 17, s. 1, ss. 61-71, 2019.
[80] T. Demir, Ö. Akpınar, H. Kara ve H. Güngör, “Nar kabuğundan antimikrobiyal ve antioksidan aktiviteye sahip fenolik bileşiklerin ekstraksiyon koşullarının optimizasyonu,” Gıda, c. 44, s. 2, ss. 369- 382, 2019.
[81] M. Huleihel, V. Ishanu, J. Tal ve S.M. Arad, “Antiviral effect of red microalgal polysaccharides on Herpes simplex and Varicella zoster viruses,” Journal of Applied Phycology, c. 13, s. 2, ss. 127-134, 2001.
[82] C.C. Wen, Y.H. Kuo, J.T. Jan, P.H. Liang, S.Y. Wang, H.G. Liu ve C.C. Hou, “Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus,” Journal of Medicinal Chemistry, c. 50, s. 17, ss. 4087-4095, 2007.
[83] J.M.R. Bettega, H. Teixeira, V.L. Bassani, C.R.M. Barardi ve C.M.O. Simões, “Evaluation of the antiherpetic activity of standardized extracts of Achyrocline satureioides,” Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, c. 18, s. 10, ss. 819-823, 2004.
[84] L. Kong, S. Li, Q. Liao, Y. Zhang, R. Sun, X. Zhu ve Y. Zhu, “Oleanolic acid and ursolic acid: novel hepatitis C virus antivirals that inhibit NS5B activity,” Antiviral Research, c. 98, s. 1, ss. 44-53, 2013.
[85] C H. Zhao, J. Xu, Y.Q. Zhang, L.X. Zhao ve B. Feng, “Inhibition of human enterovirus 71 replication by pentacyclic triterpenes and their novel synthetic derivatives,” Chemical and Pharmaceutical Bulletin, c. 62, s. 8, ss. 764-771, 2014.
[86] P. Josling, “Preventing the common cold with a garlic supplement: a double-blind, placebocontrolled survey,” Advances in Therapy, c. 18, s. 4, ss. 189-193, 2001.
[87] R.H. Wölbling ve K. Leonhardt, “Local therapy of herpes simplex with dried extract from Melissa officinalis,” Phytomedicine, c. 1, s. 1, ss. 25-31, 1994.
[88] P.J. Houghton, T.Z. Woldemariam, A.I. Khan, A. Burke ve N. Mahmood, “Antiviral activity of natural and semi-synthetic chromone alkaloids” Antiviral Research, c. 25, s. 3, ss. 235-244, 1994.
[89] B.S. Konigheim, M.E. Goleniowski ve M.S. Contigiani, “Cytotoxicity and antiviral activity of a lignan extracted from Larrea divaricata,” Drug Design Reviews-Online, c. 2, s. 1, ss. 81-83, 2005. [90] X. Li, Y. Liu, T. Wu, Y. Jin, J. Cheng, C. Wan ve W. Shi, “The antiviral effect of baicalin on enterovirus 71 in vitro,” Viruses, c. 7, s. 8, ss. 4756-4771, 2015.
[91] J.L. Castrillo ve L.U.I.S. Carrasco, “Action of 3-methylquercetin on poliovirus RNA replication,” Journal of Virology, c. 61, s. 10, ss. 3319-3321, 1987.
[92] J.B. McMahon, M.J. Currens, R.J. Gulakowski, R.W. Buckheit, C. Lackman-Smith, Y. F. Hallock ve M.R. Boyd, “Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus- induced cell killing by at least two distinct mechanisms” Antimicrobial Agents and Chemotherapy, c. 39, s. 2, ss. 484-488, 1995.
[93] J. Renard-Nozaki, T. Kim, Y. Imakura, M. Kihara ve S. Kobayashi, “Effect of alkaloids isolated from Amaryllidaceae on herpes simplex virüs,” Research in Virology, c. 140, ss. 115-128, 1989.
[94] I. Dikici, I. Mehmetoglu, N. Dikici, M. Bitirgen ve S. Kurban, “Investigation of oxidative stress and some antioxidants in patients with acute and chronic viral hepatitis B and the effect of interferon-α treatment,” Clinical Biochemistry, c. 38, s. 12, ss. 1141-1144, 2005.
[95] J. Olivero-Verbel ve L. Pacheco-Londoño, “Structure-activity relationships for the anti-HIV activity of flavonoids,” Journal of Chemical İnformation and Computer Sciences, c. 42, s. 5, ss. 1241- 1246, 2002.
[96] H. Fortin, S. Tomasi, P. Jaccard, V. Robin ve J. Boustie, “A Prenyloxycoumarin from Psiadia dentata,” Chemical and Pharmaceutical Bulletin, c. 49, s. 5, ss. 619-621, 2001.
[97] M. Wink, “Potential of DNA Intercalating Alkaloids and Other Plant Secondary Metabolites against SARS-CoV-2 Causing COVID-19,” Diversity, c. 12, s. 5, ss. 175-185, 2020.
[98] S.Y. Lyu, J.Y. Rhim ve W.B. Park, “Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro,” Archives of Pharmacal Research, c. 28, s. 11, ss. 1293-1301, 2005.
[99] R. Naithani, R.G. Mehta, D. Shukla, S.N. Chandersekera ve R.M. Moriarty, “Antiviral activity of phytochemicals: a current perspective. In Dietary Components and Immune Function,” Humana Press, Totowa, NJ, pp. 421-468, 2010.
[100] B.K. Kim, A.R. Cho ve D.J. Park, “Enhancing oral bioavailability using preparations of apigenin-loaded W/O/W emulsions: In vitro and in vivo evaluations, Food Chemistry, c. 206, ss. 85-91, 2016.
[101] A. Seyfoddin ve R. Al-Kassas, “Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir” Drug Development and İndustrial Pharmacy, c. 39, s. 4, ss. 508-519, 2013.
[102] A. Gürbüz, S. Güngör ve M.S. Erdal, “Deriye ilaç uygulanması için transetozomların formülasyonu ve in vitro karakterizasyonu,” Sağlık Bilimlerinde İleri Araştırmalar Dergisi, c. 2, s. 2, ss. 51-59, 2019.
[103] R.N. Gürsoy ve Ö. Çevik, “Kendiliğinden emülsifiye olabilen ilaç taşıyıcı sistemler ve farmasötik alanda uygulamaları,” Hacettepe Üniversitesi Eczacılık Fakültesi Dergisi, c. 2, ss. 151-170, 2011.

APA	DEMİR T, AKPINAR O (2021). Fitokimyasalların Antiviral Etkileri. , 1519 - 1535. 10.29130/dubited.892487
Chicago	DEMİR Tuğba,AKPINAR OZLEM Fitokimyasalların Antiviral Etkileri. (2021): 1519 - 1535. 10.29130/dubited.892487
MLA	DEMİR Tuğba,AKPINAR OZLEM Fitokimyasalların Antiviral Etkileri. , 2021, ss.1519 - 1535. 10.29130/dubited.892487
AMA	DEMİR T,AKPINAR O Fitokimyasalların Antiviral Etkileri. . 2021; 1519 - 1535. 10.29130/dubited.892487
Vancouver	DEMİR T,AKPINAR O Fitokimyasalların Antiviral Etkileri. . 2021; 1519 - 1535. 10.29130/dubited.892487
IEEE	DEMİR T,AKPINAR O "Fitokimyasalların Antiviral Etkileri." , ss.1519 - 1535, 2021. 10.29130/dubited.892487
ISNAD	DEMİR, Tuğba - AKPINAR, OZLEM. "Fitokimyasalların Antiviral Etkileri". (2021), 1519-1535. https://doi.org/10.29130/dubited.892487

APA	DEMİR T, AKPINAR O (2021). Fitokimyasalların Antiviral Etkileri. Düzce Üniversitesi Bilim ve Teknoloji Dergisi, 9(4), 1519 - 1535. 10.29130/dubited.892487
Chicago	DEMİR Tuğba,AKPINAR OZLEM Fitokimyasalların Antiviral Etkileri. Düzce Üniversitesi Bilim ve Teknoloji Dergisi 9, no.4 (2021): 1519 - 1535. 10.29130/dubited.892487
MLA	DEMİR Tuğba,AKPINAR OZLEM Fitokimyasalların Antiviral Etkileri. Düzce Üniversitesi Bilim ve Teknoloji Dergisi, vol.9, no.4, 2021, ss.1519 - 1535. 10.29130/dubited.892487
AMA	DEMİR T,AKPINAR O Fitokimyasalların Antiviral Etkileri. Düzce Üniversitesi Bilim ve Teknoloji Dergisi. 2021; 9(4): 1519 - 1535. 10.29130/dubited.892487
Vancouver	DEMİR T,AKPINAR O Fitokimyasalların Antiviral Etkileri. Düzce Üniversitesi Bilim ve Teknoloji Dergisi. 2021; 9(4): 1519 - 1535. 10.29130/dubited.892487
IEEE	DEMİR T,AKPINAR O "Fitokimyasalların Antiviral Etkileri." Düzce Üniversitesi Bilim ve Teknoloji Dergisi, 9, ss.1519 - 1535, 2021. 10.29130/dubited.892487
ISNAD	DEMİR, Tuğba - AKPINAR, OZLEM. "Fitokimyasalların Antiviral Etkileri". Düzce Üniversitesi Bilim ve Teknoloji Dergisi 9/4 (2021), 1519-1535. https://doi.org/10.29130/dubited.892487